AbCellera · 3 weeks ago
Medical Director - Clinical Development - Endocrinology and Autoimmune Diseases
AbCellera is a clinical stage biotech company developing antibody therapeutics for endocrine and autoimmune diseases. The Medical Director will provide medical and scientific leadership for pipeline programs, overseeing clinical trials and ensuring compliance with safety and regulatory standards.
BiotechnologyMedicalTherapeutics
Responsibilities
Leading the medical strategy for assigned clinical development programs in endocrinology and/or autoimmune diseases
Designing and authoring clinical protocols (Phase 1-3), investigator brochures, clinical study reports (CSRs), and regulatory documents (IND, CTA)
Serving as the Medical Monitor for assigned trials, overseeing patient eligibility, safety, and protocol adherence
Interpreting clinical trial data, including safety, efficacy, and pharmacokinetics/pharmacodynamics (PK/PD), and translate findings into actionable development strategy
Providing medical expertise for the ongoing assessment and management of patient safety, including reviewing cumulative safety data, serious adverse events (SAEs) and contributing to safety reports (DSURs)
Ensuring all clinical development activities are conducted in accordance with Good Clinical Practice (GCP), relevant regulatory requirements, and company standard operating procedures (SOPs)
Serving as the primary clinical contact for assigned programs to internal teams, external investigators, and regulatory agencies
Establishing and maintaining collaborative relationship with medical experts and investigators in the assigned therapeutic areas of development
Collaborating closely with cross-functional teams, including Translational Science, Clinical Operations, Regulatory Affairs, Biostatistics, and Corporate Development
Developing publications, present data and strategy to governance committees and at external meetings
Qualification
Required
M.D. (Doctor of Medicine) or equivalent degree
12+ years of clinical development and leadership experience in the pharmaceutical or biotechnology industry
Proven track record in the design, execution, and analysis of Phase 1-2 clinical trials
Excellent communication, presentation, and interpersonal skills, and are capable of influencing strategy across all levels of the organization
Experience with biologic agents (such as monoclonal antibodies), and/or novel modalities (bispecifics, T-cell engagers, ADC)
Experience interacting with major regulatory agencies (FDA, Health Canada, EMA)
Experience with translational medicine and biomarker development in clinical trials
Preferred
Board Certification or eligibility in Endocrinology, Rheumatology, or Internal Medicine
Benefits
Equity
Annual bonus dependent on team and company performance
6% (non-match) RRSP contribution
CAD $1,500 annual Active Lifestyle Allowance
Annual vacation
Professional development opportunities
Comprehensive health benefits
Company
AbCellera
AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.
Funding
Current Stage
Public CompanyTotal Funding
$886.98MKey Investors
Government of CanadaDCVC Bio
2023-05-24Grant· $515.76M
2020-12-10IPO
2020-05-27Series B· $105M
Recent News
2025-12-20
2025-12-18
2025-11-11
Company data provided by crunchbase